Evidence map›Paper›PMID 36260814›Full record

ArticleACS applied bio materials2022

Ionic Liquids as Biocompatible Antibacterial Agents: A Case Study on Structure-Related Bioactivity on

Margarida M Fernandes, Estela O Carvalho, Daniela M Correia, José M S S Esperança, Jorge Padrão, Kristina Ivanova, Javier Hoyo, Tzanko Tzanov, Senentxu Lanceros-Mendez

Open access · hybridAbstract read
In one paragraph

Article in ACS applied bio materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biocompatible Liquid Embolic for the Treatment of Microvascular Hemorrhage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Margarida M FernandesCentre of Physics, University of Minho, Braga4710-057, Portugal.ORCID 0000-0002-1529-3702
Estela O CarvalhoCentre of Physics, University of Minho, Braga4710-057, Portugal.
Daniela M CorreiaCentre of Physics, University of Minho, Braga4710-057, Portugal.ORCID 0000-0002-3118-4717
José M S S EsperançaLAQV, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516Caparica, Portugal.ORCID 0000-0001-9615-8678
Jorge PadrãoCentre for Textile Science and Technology, University of Minho, Campus de Azurém, Guimarães4800-058, Portugal.
Kristina IvanovaGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, 08222Terrassa, Spain.
Javier HoyoGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, 08222Terrassa, Spain.
Tzanko TzanovGrup de Biotecnologia Molecular i Industrial, Department of Chemical Engineering, Universitat Politècnica de Catalunya, 08222Terrassa, Spain.ORCID 0000-0002-8568-1110
Senentxu Lanceros-MendezBCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940Leioa, Spain.ORCID 0000-0001-6791-7620
Universitat Politècnica de Catalunya · ESUniversity of Minho · PTIkerbasque · ESRede de Química e Tecnologia · PTUniversity of Trás-os-Montes and Alto Douro · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential of ionic liquids (ILs) to be used as antimicrobial agents for biomedical applications has been hindered by the fact that most of them are cytotoxic toward mammalian cells. Understanding the mechanism of bacterial and mammalian cellular damage of ILs is key to their safety design. In this work, we evaluate the antimicrobial activity and mode of action of several ILs with varying anions and cations toward the clinically relevant Gram-negative

Indexed as

Ionic LiquidsAnimalsAnionsAnti-Bacterial AgentsCationsEscherichia coliImidesMammalsAnionsAnti-Bacterial AgentsCationsImidesIonic LiquidsantimicrobialbiocompatibleEscherichia coliionic liquidssurface activity

Identifiers

PMID36260814
PMCPMC9778738
OpenAlexW4306829856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.